BC
JAZZ icon

Burney Company’s Jazz Pharmaceuticals JAZZ Stock Holding History

Burney Company’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.32M Buy
22,078
+1,472
+7% +$322K 0.14% 123
2026
Q1 		$3.9M Sell
20,606
-736
-3% -$129K 0.12% 149
2025
Q4 		$3.63M Sell
21,342
-904
-4% -$139K 0.11% 167
2025
Q3 		$2.93M Sell
22,246
-2,172
-9% -$261K 0.09% 190
2025
Q2 		$2.59M Sell
24,418
-1,094
-4% -$119K 0.09% 192
2025
Q1 		$3.17M Buy
25,512
+1,672
+7% +$218K 0.12% 165
2024
Q4 		$2.94M Buy
23,840
+4,079
+21% +$481K 0.1% 178
2024
Q3 		$2.2M Sell
19,761
-62
-0.3% -$6.79K 0.08% 209
2024
Q2 		$2.12M Buy
19,823
+377
+2% +$41.4K 0.08% 219
2024
Q1 		$2.34M Sell
19,446
-19,687
-50% -$2.41M 0.09% 212
2023
Q4 		$4.81M Buy
39,133
+16,438
+72% +$2.05M 0.2% 133
2023
Q3 		$2.94M Buy
22,695
+19,089
+529% +$2.54M 0.14% 176
2023
Q2 		$447K Sell
3,606
-12,160
-77% -$1.64M 0.02% 426
2023
Q1 		$2.31M Buy
15,766
+6,486
+70% +$959K 0.11% 205
2022
Q4 		$1.48M Sell
9,280
-669
-7% -$98K 0.07% 247
2022
Q3 		$1.33M Sell
9,949
-183
-2% -$27.8K 0.07% 254
2022
Q2 		$1.58M Sell
10,132
-620
-6% -$95.4K 0.08% 230
2022
Q1 		$1.67M Sell
10,752
-498
-4% -$72.3K 0.08% 260
2021
Q4 		$1.43M Sell
11,250
-2,847
-20% -$374K 0.06% 275
2021
Q3 		$1.84M Sell
14,097
-2,967
-17% -$448K 0.09% 236
2021
Q2 		$3.03M Buy
17,064
+248
+1% +$43K 0.14% 180
2021
Q1 		$2.76M Buy
16,816
+234
+1% +$38.5K 0.14% 185
2020
Q4 		$2.74M Sell
16,582
-419
-2% -$62.4K 0.15% 173
2020
Q3 		$2.42M Sell
17,001
-2,015
-11% -$250K 0.15% 187
2020
Q2 		$2.1M Buy
19,016
+1,844
+11% +$204K 0.14% 186
2020
Q1 		$1.71M Sell
17,172
-240
-1% -$31K 0.13% 180
2019
Q4 		$2.6M Buy
17,412
+13,506
+346% +$1.84M 0.14% 165
2019
Q3 		$501K Sell
3,906
-476
-11% -$63.8K 0.03% 317
2019
Q2 		$625K Sell
4,382
-6,489
-60% -$872K 0.04% 309
2019
Q1 		$1.55M Sell
10,871
-11,987
-52% -$1.56M 0.1% 214
2018
Q4 		$2.83M Buy
22,858
+11,894
+108% +$1.76M 0.2% 145
2018
Q3 		$1.84M Buy
+10,964
New +$1.89M 0.11% 203
2015
Q3 		– Sell
-2,560
Closed -$451K – 384
2015
Q2 		$451K Sell
2,560
-165
-6% -$29.6K 0.03% 288
2015
Q1 		$471K Buy
2,725
+235
+9% +$40.3K 0.03% 290
2014
Q4 		$408K Buy
2,490
+795
+47% +$132K 0.03% 296
2014
Q3 		$272K Sell
1,695
-250
-13% -$38.4K 0.02% 349
2014
Q2 		$286K Hold
1,945
– – 0.02% 355
2014
Q1 		$270K Buy
1,945
+100
+5% +$15.1K 0.02% 355
2013
Q4 		$234K Buy
+1,845
New +$191K 0.02% 383

Other funds holding JAZZ

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BCM
BTC Capital Management Des Moines, Iowa $1.65B AUM 27.85% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
OLA
Oliver Luxxe Assets Gladstone, New Jersey $680M AUM 47.51% 1-Year Est. Return

Burney Company's JAZZ Position: Q2 2026 in Review

Burney Company increased its Jazz Pharmaceuticals (JAZZ) stake by 7.1% in Q2 2026, buying an estimated $322K and bringing the position to 22,078 shares worth $5.32M. The position accounts for 0.14% of the portfolio, ranked #123.

Burney Company first reported a position in JAZZ in Q4 2013 and has held it in 39 quarters since. 69 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Burney Company held 22,078 shares of Jazz Pharmaceuticals worth $5.32M as of Q2 2026.
  • Burney Company bought 1,472 Jazz Pharmaceuticals shares in Q2 2026, an estimated $322K.
  • Jazz Pharmaceuticals made up 0.14% of Burney Company's portfolio in Q2 2026, its #123 holding.
  • Burney Company first reported a position in Jazz Pharmaceuticals in Q4 2013 and has held it in 39 quarters since.
  • 69 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Burney Company's 13F filing for Q2 2026, filed 15 Jul 2026.